Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 16,400 | 13,690 | 7,167 | 934 | 5,431 |
| Cost of Goods | 1,687 | 1,283 | 817 | N/A | N/A |
| Gross Profit | 14,713 | 12,407 | 6,350 | 334 | 5,431 |
| Operating Expenses | 187,454 | 199,960 | 200,990 | 212,657 | 191,874 |
| Operating Income | -172,054 | -187,270 | -193,823 | -211,723 | -186,443 |
| Other Income | 10,150 | 10,357 | 9,237 | 9,502 | 13,136 |
| Pre-tax Income | -161,904 | -176,913 | -184,586 | -202,221 | -173,307 |
| Income Tax | N/A | N/A | N/A | 254 | 254 |
| Net Income Continuous | -161,904 | -176,913 | -184,586 | -202,475 | -173,561 |
| Net Income | $-161,904 | $-176,913 | $-184,586 | $-202,475 | $-173,561 |
| EPS Basic Total Ops | -2.49 | -3.04 | -3.18 | -3.51 | -3.09 |
| EPS Basic Continuous Ops | -2.49 | -3.04 | -3.18 | -3.52 | -3.09 |
| EPS Diluted Total Ops | -2.49 | -3.04 | -3.18 | -3.51 | -3.09 |
| EPS Diluted Continuous Ops | -2.49 | -3.04 | -3.18 | -3.52 | -3.09 |
| EPS Diluted Before Non-Recurring Items | -2.49 | -3.04 | -3.18 | -3.51 | -3.09 |
| EBITDA(a) | $-176,822 | $-191,592 | $-197,916 | $-214,881 | $-187,335 |